World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
115
Citations
72810
World Ranking
4437
National Ranking
2419

Overview

Richard C. Becker is affiliated with the University of Cincinnati in the United States. Their primary research fields are Medicine, with a particular focus on Cardiology and Cardiovascular Medicine.

Their work spans several main topics related to cardiac health, including:

  • Atrial Fibrillation Management and Outcomes
  • Cardiac Valve Diseases and Treatments
  • Cardiac Arrhythmias and Treatments

Among recent publications, a notable paper is "Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve," published in 2020 in the American Heart Journal.

Frequent co-authors collaborating with Becker include:

  • Oliver K. Jawitz
  • Tracy Y. Wang
  • Renato D. Lópes
  • Alma Chavez
  • Brittanny Boyer

Their contributions have appeared primarily in the American Heart Journal, reflecting their engagement with cardiovascular research communities and clinical study publications.

Best Publications

  • Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

    Manesh R. Patel;Kenneth W. Mahaffey;Jyotsna Garg;Guohua Pan

  • Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

    Lars Wallentin;Richard C. Becker;Andrzej Budaj;Christopher P. Cannon

  • Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate

    Laurent Bonello;Udaya S. Tantry;Rossella Marcucci;Ruediger Blindt

  • Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis

    S. G. Chu;R. C. Becker;P. B. Berger;D. L. Bhatt

  • Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation

    Abstr Act;James D. Douketis;Alex C. Spyropoulos;Scott Kaatz

  • The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

    James D. Douketis;Peter B. Berger;Andrew S. Dunn;Amir K. Jaffer

  • Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

    James J Ferguson;Robert M Califf;Elliott M Antman;Marc Cohen

  • Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

    Iacopo Olivotto;Artur Oreziak;Roberto Barriales-Villa;Theodore P. Abraham

  • Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding

    Udaya S. Tantry;Laurent Bonello;Daniel Aradi;Matthew J. Price

  • Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

    Christopher P Cannon;Robert A Harrington;Stefan James;Diego Ardissino

  • Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment

    Keith A. A. Fox;Jonathan P. Piccini;Daniel Wojdyla;Richard C. Becker

  • Platelet Inhibition with Cangrelor in Patients Undergoing PCI

    Robert A. Harrington;Gregg W. Stone;Steven McNulty;Harvey D. White

  • Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial

    Lars Wallentin;Stefan James;Robert F Storey;Martin Armstrong

  • COVID-19 update: Covid-19-associated coagulopathy.

    Richard C. Becker

  • Platelet functions beyond hemostasis

    S. S. Smyth;R. P. Mcever;A. S. Weyrich;C. N. Morrell

  • Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease

    Mark I Furman;Stephen E Benoit;Marc R Barnard;C.Robert Valeri

  • Response to Letter Regarding Article, “Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R2CHADS2 Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts”

    Jonathan P. Piccini;Susanna R. Stevens;YuChiao Chang;Daniel E. Singer

  • Sex differences in mortality following acute coronary syndromes.

    Jeffrey S. Berger;Laine Elliott;Dianne Gallup;Matthew Roe

  • Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.

    Investigators;John H Alexander;Richard C Becker

  • Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial Infarction.

    Frederick A. Spencer;Robert J. Goldberg;Richard C. Becker;Joel M. Gore

Frequent Co-Authors

Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University
Manesh R. Patel
Manesh R. Patel Duke University
Keith A.A. Fox
Keith A.A. Fox University of Edinburgh
Stefan James
Stefan James Uppsala University
Daniel E. Singer
Daniel E. Singer Harvard University
Robert F. Storey
Robert F. Storey University of Sheffield
Lars Wallentin
Lars Wallentin Uppsala University
Graeme J. Hankey
Graeme J. Hankey University of Western Australia
Jonathan P. Piccini
Jonathan P. Piccini Duke University
Jonathan L. Halperin
Jonathan L. Halperin Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine goes beyond traditional medical school. Today, many students are exploring alternative healthcare pathways that offer flexibility, affordability, and quicker entry into the workforce. If you're interested in medical support roles, check out the best online medical billing and coding schools to gain skills essential for managing health records, insurance, and billing processes.

For those aiming to start their nursing careers quickly, some schools offer an lpn program no entrance exam required. This makes it easier to begin training as a licensed practical nurse without lengthy or complicated admissions tests.

Interested in leadership or administrative roles within healthcare? Earning a healthcare administration degree online accredited can prepare you for positions in hospital management, department operations, or policy making.

Finally, registered nurses seeking advanced clinical qualifications can explore asn to fnp bridge programs. These accelerated pathways help nurses move quickly from associate degrees to becoming Family Nurse Practitioners, expanding their career and earning potential.

Best Scientists Citing Richard C. Becker

Trending Scientists